Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07300033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is an open-label, randomized, two-treatment, two-period crossover study evaluating the bioequivalence of liquid metformin formulations at 100 mg/mL and 250 mg/mL compared with immediate-release metformin tablets in healthy adult subjects. Each participant will receive both treatments in randomized sequence with an adequate washout interval between periods. Serial blood samples will be collected to assess metformin pharmacokinetics, and safety will be monitored throughout the study.
Trial Details
NCT Number NCT07300033
Lead Sponsor Aspargo Labs, Inc
Conditions
(from sponsor)		 Healthy Volunteer
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov